These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 36417763)

  • 1. Optical genome mapping in acute myeloid leukemia: a multicenter evaluation.
    Levy B; Baughn LB; Akkari Y; Chartrand S; LaBarge B; Claxton D; Lennon PA; Cujar C; Kolhe R; Kroeger K; Pitel B; Sahajpal N; Sathanoori M; Vlad G; Zhang L; Fang M; Kanagal-Shamanna R; Broach JR
    Blood Adv; 2023 Apr; 7(7):1297-1307. PubMed ID: 36417763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Benchmarking of Optical Genome Mapping and Chromosomal Microarray Reveals High Technological Concordance in CNV Identification and Additional Structural Variant Refinement.
    Barseghyan H; Pang AWC; Clifford B; Serrano MA; Chaubey A; Hastie AR
    Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of complex chromosome rearrangements using optical genome mapping.
    Qu J; Li S; Yu D
    Gene; 2023 Oct; 884():147688. PubMed ID: 37543218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-generation cytogenetics: Comprehensive assessment of 52 hematological malignancy genomes by optical genome mapping.
    Neveling K; Mantere T; Vermeulen S; Oorsprong M; van Beek R; Kater-Baats E; Pauper M; van der Zande G; Smeets D; Weghuis DO; Stevens-Kroef MJPL; Hoischen A
    Am J Hum Genet; 2021 Aug; 108(8):1423-1435. PubMed ID: 34237281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical genome mapping enables constitutional chromosomal aberration detection.
    Mantere T; Neveling K; Pebrel-Richard C; Benoist M; van der Zande G; Kater-Baats E; Baatout I; van Beek R; Yammine T; Oorsprong M; Hsoumi F; Olde-Weghuis D; Majdali W; Vermeulen S; Pauper M; Lebbar A; Stevens-Kroef M; Sanlaville D; Dupont JM; Smeets D; Hoischen A; Schluth-Bolard C; El Khattabi L
    Am J Hum Genet; 2021 Aug; 108(8):1409-1422. PubMed ID: 34237280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML/MDS patients.
    Gerding WM; Tembrink M; Nilius-Eliliwi V; Mika T; Dimopoulos F; Ladigan-Badura S; Eckhardt M; Pohl M; Wünnenberg M; Farshi P; Reimer P; Schroers R; Nguyen HP; Vangala DB
    Int J Cancer; 2022 Jun; 150(12):1998-2011. PubMed ID: 35064925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical Genome Mapping as a Next-Generation Cytogenomic Tool for Detection of Structural and Copy Number Variations for Prenatal Genomic Analyses.
    Sahajpal NS; Barseghyan H; Kolhe R; Hastie A; Chaubey A
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33799648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical Genome Mapping in Routine Cytogenetic Diagnosis of Acute Leukemia.
    Soler G; Ouedraogo ZG; Goumy C; Lebecque B; Aspas Requena G; Ravinet A; Kanold J; Véronèse L; Tchirkov A
    Cancers (Basel); 2023 Apr; 15(7):. PubMed ID: 37046792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping.
    Rack K; De Bie J; Ameye G; Gielen O; Demeyer S; Cools J; De Keersmaecker K; Vermeesch JR; Maertens J; Segers H; Michaux L; Dewaele B
    Am J Hematol; 2022 May; 97(5):548-561. PubMed ID: 35119131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Validation and Diagnostic Utility of Optical Genome Mapping in Prenatal Diagnostic Testing.
    Sahajpal NS; Mondal AK; Fee T; Hilton B; Layman L; Hastie AR; Chaubey A; DuPont BR; Kolhe R
    J Mol Diagn; 2023 Apr; 25(4):234-246. PubMed ID: 36758723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical Genome Mapping as an Alternative to FISH-Based Cytogenetic Assessment in Chronic Lymphocytic Leukemia.
    Valkama A; Vorimo S; Kumpula TA; Räsänen H; Savolainen ER; Pylkäs K; Mantere T
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of cryptic balanced chromosomal rearrangements using high-resolution optical genome mapping.
    Zhang S; Pei Z; Lei C; Zhu S; Deng K; Zhou J; Yang J; Lu D; Sun X; Xu C; Xu C
    J Med Genet; 2023 Mar; 60(3):274-284. PubMed ID: 35710108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic structural variants analysis in leukemia by a novel cytogenetic technique: Optical genome mapping.
    Lu S; Liu K; Wang D; Ye Y; Jiang Z; Gao Y
    Cancer Sci; 2024 Nov; 115(11):3543-3551. PubMed ID: 39180374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Utility of Optical Genome Mapping for Improved Cytogenomic Analysis of Gliomas.
    Singh H; Sahajpal NS; Mondal AK; Burke SL; Farmaha J; Alptekin A; Vashisht A; Jones K; Vashisht V; Kolhe R
    Biomedicines; 2024 Jul; 12(8):. PubMed ID: 39200124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optical Genome Mapping as a Tool to Unveil New Molecular Findings in Hematological Patients with Complex Chromosomal Rearrangements.
    Coccaro N; Zagaria A; Anelli L; Tarantini F; Tota G; Conserva MR; Cumbo C; Parciante E; Redavid I; Ingravallo G; Minervini CF; Minervini A; Specchia G; Musto P; Albano F
    Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38137002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical genome mapping for structural variation analysis in hematologic malignancies.
    Smith AC; Neveling K; Kanagal-Shamanna R
    Am J Hematol; 2022 Jul; 97(7):975-982. PubMed ID: 35560245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetics and the Revolution of Optical Genome Mapping in the Diagnosis of Diseases.
    Al-Amer OM; Khubrani Y
    Discov Med; 2024 Sep; 36(188):1780-1788. PubMed ID: 39327241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of optical genome mapping for detecting chromosomal translocation in clinical cytogenetics.
    Dai P; Zhu X; Pei Y; Chen P; Li J; Gao Z; Liang Y; Kong X
    Mol Genet Genomic Med; 2022 Jun; 10(6):e1936. PubMed ID: 35384386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optical genome mapping improves the accuracy of classification, risk stratification, and personalized treatment strategies for patients with acute myeloid leukemia.
    Loghavi S; Wei Q; Ravandi F; Quesada AE; Routbort MJ; Hu S; Toruner GA; Wang SA; Wang W; Miranda RN; Li S; Xu J; DiNardo CD; Daver N; Kadia TM; Issa GC; Kantarjian HM; Medeiros LJ; Tang G
    Am J Hematol; 2024 Oct; 99(10):1959-1968. PubMed ID: 39016111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of fluorescence in situ hybridization for the detection of genomic aberrations in older patients with acute myeloid leukemia.
    Fröhling S; Kayser S; Mayer C; Miller S; Wieland C; Skelin S; Schlenk RF; Döhner H; Döhner K;
    Haematologica; 2005 Feb; 90(2):194-9. PubMed ID: 15710571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.